Voloridge Investment Management »

Autolus Therapeutics Plc spon ads shares owned by Voloridge Investment Management

Quarter-by-quarter ownership of Autolus Therapeutics Plc spon ads (AUTL) shares owned by Voloridge Investment Management from 13F filings

Historical chart of Voloridge Investment Management investment in Autolus Therapeutics Plc spon ads

Tip: Access up to 7 years of quarterly data

All positions including Autolus Therapeutics Plc spon ads held by Voloridge Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Autolus Therapeutics Plc spon ads by Voloridge Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $439k 121k 3.63
2024-06-30 $517k 149k 3.48
2024-03-31 $3.3M 513k 6.38

More positions owned by Voloridge Investment Management

Ishares Tr Core S&p500 Etf (IVV)
AmerisourceBergen (COR)
Mastercard Incorporated Cl A (MA)
MercadoLibre (MELI)
Merck & Co (MRK)
Marsh & McLennan Companies (MMC)
Apple (AAPL)
Cme (CME)
AutoZone (AZO)
Cava Group Ord (CAVA)
Illinois Tool Works (ITW)
McKesson Corporation (MCK)
Lockheed Martin Corporation (LMT)
Waste Management (WM)
TJX Companies (TJX)

View all positions for Voloridge Investment Management

Top funds holding Autolus Therapeutics Plc spon ads

Syncona Portfolio
Blackstone Group
Deep Track Capital
Polygon Management
Armistice Capital
Frazier Life Sciences Management
Affinity Asset Advisors
BlackRock
BlackRock
T. Rowe Price Associates
Deerfield Management Company
Laurion Capital Management
Morgan Stanley
Dr. Jeffrey R. Jay, M.D.
Stempoint Capital

View all funds holding Autolus Therapeutics Plc spon ads